BioSpace News Archive

Business

Iveric Bio to Report Third Quarter 2022 Financial Results and Host Conference Call on Thursday, November 3, 2022

IVERIC bio, Inc. (Nasdaq: ISEE) today announced that it will report its third quarter 2022 financial and operating results on Thursday, November 3, 2022.

October 27, 2022
·
2 min read
Stevanato Group and DWK Life Sciences Sign Non-Exclusive Distribution Agreement for EZ-fill® Platform Products

Stevanato Group S.p.A. and DWK Life Sciences announced they have entered a non-exclusive agreement for the distribution and sale of the EZ-fill® Ready-to-Use solutions by Stevanato Group.

October 27, 2022
·
3 min read
Business

Alnylam Pharmaceuticals Reports Third Quarter 2022 Financial Results and Highlights Recent Period Activity

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the third quarter ended September 30, 2022 and reviewed recent business highlights.

October 27, 2022
·
31 min read
Business

Indivior Announces Q3 2022 Financial Results

Indivior PLC (LON: INDV) today announced its financial results for the period ending September 30, 2022 .

October 27, 2022
·
1 min read
Drug Development

Aphaia Pharma Announces Enrollment of First Patient in Phase 2 Study of APH-012 for Chronic Weight Management in Individuals with Obesity

Aphaia Pharma today announced that it has enrolled the first patient as part of a Phase 2 study evaluating the safety and efficacy of its lead drug candidate, APH-012, to induce weight loss in individuals with obesity.

October 27, 2022
·
3 min read
Lone Star Bio

Salarius Pharmaceuticals Presents Favorable Preclinical Data on SP-3164 at the 5th Annual Targeted Protein Degradation Conference

Salarius Pharmaceuticals, Inc. today announced favorable preclinical data that support continued development of the company’s Targeted Protein Degrader (TPD), SP-3164.

October 27, 2022
·
7 min read
Business

Cryoport to Report Third Quarter 2022 Financial Results on November 3, 2022

Cryoport, Inc. today announced that the Company will report financial results for the three months period ended September 30, 2022 (third quarter 2022) on Thursday, November 3, 2022.

October 27, 2022
·
4 min read
Drug Development

Q32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of ADX-914 for Atopic Dermatitis

Q32 Bio and Horizon Therapeutics plc, announced that the first patient has been dosed in a randomized, double-blind, placebo-controlled, Phase 2 multi-center proof-of-concept study in adult subjects to evaluate the safety and efficacy of ADX-914 in persistent, moderate-to-severe atopic dermatitis.

October 27, 2022
·
6 min read
Mirion Technologies to Present at the 2022 Baird Industrial Conference

Mirion Technologies, Inc. (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at the 2022 Baird Industrial Conference in Chicago, IL.

October 27, 2022
·
1 min read
Business

Viveve to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10, 2022

Viveve Medical, Inc. today announced that it will report its third quarter 2022 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, November 10, 2022.

October 27, 2022
·
4 min read